Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: A randomized, double-blinded placebo-controlled trial

Human Reproduction

Volumn 16, Issue 8, 2001, Pages 1625-1631

  Ng, Ernest Hung Yu ^a,b   Wat, Nelson Ming Sun ^a   Ho, Pak Chung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Clomiphene resistant; Metformin; Polycystic ovaries

Indexed keywords

CLOMIFENE CITRATE; LEPTIN; METFORMIN; PLACEBO; TESTOSTERONE;

ADULT; ANOVULATION; ARTICLE; BODY MASS; CHINESE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE RESISTANCE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FEMALE INFERTILITY; HORMONE RELEASE; HUMAN; INSULIN SENSITIVITY; METABOLIC BALANCE; OVARY POLYCYSTIC DISEASE; OVULATION; OVULATION INDUCTION; POPULATION RESEARCH; PREGNANCY RATE; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL; TRANSVAGINAL ECHOGRAPHY; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0034886493     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/16.8.1625     Document Type: Article

References (36)

1. Can metformin reduce insulin resistance in polycystic ovary syndrome?
2. Multifollicular ovaries: Clinical and endocrine features and response to pulsatile gonaddotrophin releasing hormone
3. Pathogenesis of polycystic ovary syndrome - The enigma unravels?
4. Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women
5. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: A long term follow-up focusing on natural history and circulating hormones
6. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome
7. Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus
8. Insulin resistance and the polycystic ovary syndrome: Mechanisms and implication for pathogenesis
9. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome
10. Effects of metformin on insulin secretion, insulin action and ovarian steroidogenesis in women with polycystic ovary syndrome
11. The number of follicles and ovarian volume in the assessment of response to clomiphene citrate treatment in polycystic ovarian syndrome
12. Polycystic ovary syndrome
13. Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome
14. Polycystic ovary syndrome - From gynaecological curiosity to multisystem endocrinopathy
15. Quantification of the relationship between insulin sensitivity and β cell function in human subjects
16. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome
17. Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome
18. Hormonal profile of the cycle in 68 normally menstruating women
19. Clinical and laboratory predictors of clomiphene response
20. Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity
21. High ovulatory rates with the use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome
22. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation
23. Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome
24. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c 17 activity and serum androgens
25. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome
26. Insulin sensitizing agents and polycystic ovary syndrome
27. Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhea
28. Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: The difference between responders and non-responders
29. Which hormone tests for the diagnosis of polycystic ovary syndrome?
30. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries
31. Female infertility: Treatment options for complicated cases
32. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome
33. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone
34. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
35. Menstrual cyclicity after metformin therapy in polycystic ovary syndrome